Nearsightedness is a major problem among children and young adults as it can lead to real eye problems later in life, including serious retinal diseases and vision loss. Studies have shown that myopia can progress to a more dangerous level by the time a child is a teen or young adult. For instance, in March 2021, a study published by British Journal of Ophthalmology concluded that myopia progression among children aged 7–9 years (33.1%) and 10–12 years (29.4%) was higher as compared to other groups (at most 22.1%). Even amounts of nearsightedness -4.00 units or more, increases the risk of myopia progressing into a more serious form by the time the child reaches teen age, so it is important to treat myopia early to prevent it from getting worse.

Various treatments are available to control myopia, among which the latest myopia control method involves a special contact lens that is designed to simultaneously correct myopia and prevent myopia progression. It works by using a dual-focus approach whereby the central area of the lens contains myopia correction and alternating rings surround this region, with each ring being configured to provide either myopia control or near addition.

Market Dynamics

The major driving factor that is responsible for boosting the myopia control lenses market growth is the ever-increasing incidence of myopia, mostly among the children and the growing adults. With its rise, there is increase in demand for solutions to control its spread which ultimately requires the adoption of myopia control lenses as a preventative measure to address the problem and lower the possible hazards which is motivated by the increased awareness of and concern for eye health. In August 2023, according to an article published by Modern Optometry, the myopia's global incidence is increasing, rising from 27% in 2010 to 33% in 2020. It is anticipated that 52% of the global population will be myopic by 2050, with 10% of those people having extreme myopia.

Also, the market for myopia control lenses has grown significantly as a result of the continuous progress in lens technology. Manufacturers are creating specialty lenses with cutting-edge materials and designs to effectively stop the growth of myopia. The growing number of clinical studies and scientific evidence proves the effectiveness of myopia control lenses which  had a significant impact on market expansion. Strong proof for the efficiency of myopia control lenses has been presented by numerous studies, which has enhanced their acceptance and endorsement by eyecare specialists. For instance, on April 27, 2023, EssilorLuxottica, a manufacturer of high-quality vision care products, revealed the four-year clinical study findings of its myopia control innovation Essilor Stellest lens for the first time at the 2023 ARVO annual meeting in New Orleans,U.S.. The findings reveal that Essilor Stellest lenses continue to be effective in decreasing myopia progression and axial eye elongation in children in their fourth year.

However, the limited cognizance about controlling myopia amongst the population and the high cost of myopia lenses being high (for ex: orthokeratology lenses), is expected to hinder the market growth of the global myopia control lenses market over the fasted period.

Key features of the study:

• This report provides in-depth analysis of the global myopia control lenses market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global myopia control lenses market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Essilor International, Johnson & Johnson Vision, CooperVision, Hoya Corporation, Zeiss Group, Bausch + Lomb, Menicon Co., Ltd., SEED Co., Ltd., Alcon (Novartis), Visioneering Technologies, Inc., Paragon Vision Sciences, Euclid Systems Corporation, Art Optical Contact Lens, Inc., SynergEyes, Inc., Nevakar Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global myopia control lenses market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global myopia control lenses market

Global Myopia Control Lenses Market Detailed Segmentation:

• By Product Type:
  • Spectacle Lens
  • Contact Lens
• By Lens Type: 
  • Multifocal LensesOrthokeratology Lenses
  • Dual-focus Lenses
  • Peripheral Defocus Lenses
• By Age Group:
  • Children
  • Adults
• By Distribution Channel:
  • Optometry Clinics
  • Optical Retail Stores
  • Online Retail
• By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• By Company:
  • Essilor International* Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies

• Johnson & Johnson Vision
• CooperVision
• Hoya Corporation
• Zeiss Group
• Bausch + Lomb
• Menicon Co., Ltd.
• SEED Co., Ltd.
• Alcon (Novartis)
• Visioneering Technologies, Inc.
• Paragon Vision Sciences
• Euclid Systems Corporation
• Art Optical Contact Lens, Inc.
• SynergEyes, Inc.
• Nevakar Inc.

“*” marked represents similar segmentation in other categories in the respective section